Mirae Asset Global ETFs Holdings Portfolio holdings
AUM
$51.7B
1-Year Return
33.71%
This Quarter Return
-2.86%
1 Year Return
+33.71%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$46.9B
AUM Growth
-$324M
(-0.69%)
Cap. Flow
+$2.36B
Cap. Flow
% of AUM
5.03%
Top 10 Holdings %
Top 10 Hldgs %
20%
Holding
3,117
New
62
Increased
2,462
Reduced
519
Closed
61
Top Buys
| 1 |
CRH
CRH
|
$249M |
| 2 |
Apple
AAPL
|
$135M |
| 3 |
Palantir
PLTR
|
$135M |
| 4 |
Microsoft
MSFT
|
$114M |
| 5 |
TSMC
TSM
|
$83.2M |
Top Sells
| 1 |
ENLC
ENLINK MIDSTREAM, LLC
ENLC
|
$171M |
| 2 |
Howmet Aerospace
HWM
|
$79.7M |
| 3 |
Cameco
CCJ
|
$77.2M |
| 4 |
Trane Technologies
TT
|
$66.3M |
| 5 |
ALTM
Arcadium Lithium plc
ALTM
|
$61M |
Sector Composition
| 1 | Technology | 25.82% |
| 2 | Industrials | 17.62% |
| 3 | Energy | 13.93% |
| 4 | Materials | 9.29% |
| 5 | Consumer Discretionary | 6.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Bio-Rad Laboratories Class A
BIO
$8B
| $15.3K | ﹤0.01% |
63
-6
| -9% | -$1.46K |
|
3002
Tevogen Bio Holdings
TVGN
$170M
| $15.3K | ﹤0.01% |
14,145
+577
| +4% | +$623 |
|
3003
Astera Labs
ALAB
$31.8B
| $15.2K | ﹤0.01% |
254
-11,397
| -98% | -$680K |
|
3004
CAMP4 Therapeutics Corporation Common Stock
CAMP
$30.6M
| $15.1K | ﹤0.01% |
3,786
+156
| +4% | +$624 |
|
3005
FibroBiologics
FBLG
$24.1M
| $15K | ﹤0.01% |
16,627
+702
| +4% | +$632 |
|
3006
Acrivon Therapeutics
ACRV
$41.8M
| $14.4K | ﹤0.01% |
7,087
+312
| +5% | +$633 |
|
3007
Harvard Bioscience
HBIO
$21.3M
| $14.3K | ﹤0.01% |
25,324
+1,014
| +4% | +$574 |
|
|
BOLD
3008
Boundless Bio
BOLD
$25.7M
| $14.2K | ﹤0.01% |
9,398
+405
| +5% | +$612 |
|
3009
Prairie Operating Co
PROP
$105M
| $13.6K | ﹤0.01% |
2,539
-24,726
| -91% | -$132K |
|
3010
United Homes Group
UHG
$249M
| $13.4K | ﹤0.01% |
4,770
+1,752
| +58% | +$4.91K |
|
3011
374Water
SCWO
$59.5M
| $13.3K | ﹤0.01% |
39,143
+1,638
| +4% | +$557 |
|
3012
Century Therapeutics
IPSC
$43.6M
| $13.1K | ﹤0.01% |
27,447
+1,170
| +4% | +$557 |
|
3013
PepGen
PEPG
$45.9M
| $13.1K | ﹤0.01% |
9,289
+390
| +4% | +$548 |
|
3014
Autohome
ATHM
$3.39B
| $12.5K | ﹤0.01% |
+451
| New | +$12.5K |
|
3015
ALX Oncology
ALXO
$65.3M
| $12.3K | ﹤0.01% |
19,771
+858
| +5% | +$535 |
|
3016
Generation Bio
GBIO
$40.3M
| $12.1K | ﹤0.01% |
2,996
+125
| +4% | +$506 |
|
3017
Ovid Therapeutics
OVID
$87.5M
| $11.5K | ﹤0.01% |
37,012
+1,482
| +4% | +$462 |
|
3018
MarketWise
MKTW
$49.6M
| $11.4K | ﹤0.01% |
1,159
+51
| +5% | +$503 |
|
3019
Outlook Therapeutics
OTLK
$41.5M
| $11K | ﹤0.01% |
9,056
+390
| +5% | +$476 |
|
|
IGMS
3020
DELISTED
IGM Biosciences
IGMS
| $10.5K | ﹤0.01% |
9,096
+390
| +4% | +$448 |
|
3021
Offerpad Solutions
OPAD
$156M
| $10.3K | ﹤0.01% |
6,192
+234
| +4% | +$388 |
|
3022
American Realty Investors
ARL
$256M
| $9.56K | ﹤0.01% |
873
| – | – |
|
3023
Verrica Pharmaceuticals
VRCA
$48.3M
| $9.55K | ﹤0.01% |
2,159
+1,073
| +99% | +$4.75K |
|
3024
Nokia
NOK
$24.5B
| $9.45K | ﹤0.01% |
1,814
+96
| +6% | +$500 |
|
3025
TPG
TPG
$8.64B
| $9.25K | ﹤0.01% |
195
-31
| -14% | -$1.47K |
|